Ben is the Chief Executive Officer and a Director of KalVista. Since 2023, he served as the Company’s President, where he was given the responsibility for leading future business growth, including the development of KalVista’s commercial organization. Ben joined the Company as Chief Financial Officer in August 2016 and in 2019 was promoted to the additional role of Chief Business Officer. He has more than 25 years of industry experience as a life sciences investment banker at firms including Robertson Stephens and SunTrust and a senior executive of several public and private biotech companies including SVP & CFO of Ore Pharmaceutical Holdings and Penwest Pharmaceuticals Co. In his roles, Ben has overseen strategic planning, business development, business operations, finance, human resources, legal, and investor relations. He has completed over 50 strategic, licensing and financing transactions and raised more than $2 billion in capital.
Ben holds a BA in Quantitative Economics from Tufts University and an MBA in Finance and MA in International Relations from the University of Chicago. He served as a Naval Aviator in the U.S. Navy.
